COMMON STOCK PURCHASE WARRANT MDNA LIFE SCIENCES, INC.Security Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • New York
This Warrant is being issued pursuant to that certain Securities Purchase Agreement dated as of September 30, 2021 between the Holder and the Company (the “Securities Purchase Agreement”). In addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement.
12% CONVERTIBLE PROMISSORY NOTE DUE __, 2023Convertible Security Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • New York
THIS 12% CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 12% Convertible Promissory Notes of MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), having its principal place of business at 2054 Vista Parkway, Suite 400, West Palm Beach, FL 33411, designated as its 12% Convertible Promissory Notes due __, 2023 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).
EXHIBIT A SECURITIES PURCHASE AGREEMENT and escrow agreement MDNA Life Sciences, Inc. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made as of the ___ day of _________________, 2018 by and among MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature page hereto (each a “Purchaser” and together the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 30, 2021, between MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • Florida
THIS AGREEMENT ("Agreement") is made this 8th day of January, 2016 by and between MDNA Life Sciences, Inc., a Delaware corporation (the "Company") and Christopher C. Mitton, an individual residing at 118 Cocoplum Circle Royal Palm Beach FL 33411 (Executive).
Dated 2020Lease • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research
Executive Employment Agreement BETWEEN: MDNA Life Sciences Inc. a corporation duly incorporated under the laws of the State of Delaware, (“MDNA”) - and – Robert Poulter, of Gorham, Ontario, Canada (the "Executive")Executive Employment Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • Ontario
DATED 21 March 2019Lease Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • England and Wales
MDNA LIFE SCIENCES (UK) LIMITED (company number 05386828) whose registered office is at 83 Kingfisher House, Kingsway, Team Valley, Gateshead, Tyne & Wear NE11 OJQ
